A Phase 2, Double-Blind, Randomized Study Evaluating the Safety, Tolerability, and Efficacy of GS-4997 in Combination With Prednisolone Versus Prednisolone Alone in Subjects With Severe Alcoholic Hepatitis (AH)

Trial Profile

A Phase 2, Double-Blind, Randomized Study Evaluating the Safety, Tolerability, and Efficacy of GS-4997 in Combination With Prednisolone Versus Prednisolone Alone in Subjects With Severe Alcoholic Hepatitis (AH)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 11 Aug 2017

At a glance

  • Drugs Selonsertib (Primary) ; Prednisolone
  • Indications Alcoholic hepatitis
  • Focus Adverse reactions
  • Sponsors Gilead Sciences
  • Most Recent Events

    • 04 Apr 2017 Planned primary completion date changed from 1 Apr 2018 to 1 Jan 2018.
    • 02 Mar 2017 Planned End Date changed from 29 Jan 2018 to 1 Apr 2018.
    • 02 Mar 2017 Planned primary completion date changed from 10 Oct 2017 to 1 Apr 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top